Martin Shkreli, the founder of Turing Pharmaceuticals who is described in some quarters as the “most hated man in America,” may face new charges.
Shkreli already faces charges accusing him of defrauding investors, but his lawyers said Tuesday that a trial should be delayed because new charges may be filed.
CNBC reports that those additional charges against Shkreli and lawyer Evan Greebel should be announced within the month.
To recap, in December Shkreli was charged by the federal government with seven counts:
- Two counts of securities fraud Two counts of conspiracy to commit securities fraud Three counts of conspiracy to commit wire fraud
Shkreli, the notorious former pharma CEO, made headlines last September after he raised the price of Daraprim, a drug used to treat a parasitic infection called toxoplasmosis, by 5,000%. These charges, however, are not directly related to the price hike; they are related to events from earlier in his career while he was managing hedge funds.
Shkreli’s next court appearance is scheduled for June 6, CNBC reports.